Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial-Reference-Cited by-同舟云学术

Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial

Author:

Muro Kei¹,Itabashi Michio²,Hashida Hiroki³,Masuishi Toshiki¹⁴,Bando Hiroyuki⁵,Denda Tadamichi⁶,Yamanaka Takeharu⁷,Ohashi Yasuo⁸,Sugihara Kenichi⁹

Affiliation:

1. Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

2. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, Japan

3. Department of Surgery, Kobe City Medical Center General Hospital, Hyogo, Japan

4. Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan

5. Department of Gastroenterological surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

6. Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan

7. Department of Biostatistics and Epidemiology, Yokohama City University School of Medicine, Yokohama, Japan

8. Department Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan

9. Tokyo Medical and Dental University, Tokyo, Japan

Funder

Public Health Research Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

Reference18 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Message from the Editor-in-Chief;Japanese Journal of Clinical Oncology;2020-12-28